UPDATE: Morgan Stanley Downgrades Sage Therapeutics (SAGE) to Equalweight
Tweet Send to a Friend
(Updated - November 16, 2020 5:48 AM EST)
(updating comment)Morgan Stanley analyst Matthew Harrison downgraded Sage Therapeutics (NASDAQ: SAGE) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updating comment)Morgan Stanley analyst Matthew Harrison downgraded Sage Therapeutics (NASDAQ: SAGE) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
